Paul Kelly
Co-Founder & Venture Partner, OneVentures
2 conversations across 2 shows.
Meet the people behind the company.

Latest conversation · First Cheque
From Scalpel to Syndicate: Paul Kelly's Guide to Navigating Biotech InvestingOneVentures is a Sydney venture capital firm that invests in later-stage technology and healthcare companies. It runs three strategies: growth equity for technology companies moving from product-market fit to global scale, growth credit facilities of about $1 million to $15 million or more, and healthcare investment in clinical-stage therapeutics, medical devices and diagnostics. Dr Michelle Deaker, Dr Paul Kelly and Anne-Marie Birkill co-founded the firm, which operates five Early Stage Venture Capital Limited Partnership funds.
Sources: one-ventures.com.au, one-ventures.com.au, one-ventures.com.au
Co-Founder & Venture Partner, OneVentures
Founding & Managing Partner, OneVentures
Moments from other conversations on the network where OneVentures comes up.
“So for example, OneVentures has a VCLP. Whereas Black Nova, for example, has an ESG CLP.”
“this fund will basically mark, if they do get to the $200, OneVentures having over $1 billion under management, um, in total.”
“a couple startups that you've probably heard of, um, that OneVentures has invested in, um, you've sort of got SixClicks, uh, Flippa, the marketplace for buying and selling businesses”
“I think OneVentures had just launched at that point.”
Companies OneVentures has backed whose teams have been on the network.
Spot something wrong? Suggest a correctionUpdated 29 October 2026
Put your brand alongside the voices founders, investors and operators come to hear.
Explore sponsorshipWe're W2D1 Media — the team behind the Day One Network, and we helped build Blackbird Ventures' Wild Hearts. We turn podcasts into trust, authority and pipeline.